|
Therion Biologics Board of Directors
Therion has attracted an impressive team of biotechnology, pharmaceutical and investment professionals to its Board of Directors, providing an invaluable depth of industry experience. The group provides ongoing counsel to Therion, guiding the Company towards its next phase of late stage clinical development and product commercialization.
Therion's Board of Directors includes the following:
Ronald Saldarini, Ph.D. - Chairman of the Board
Former President, Wyeth-Lederle Vaccines and
Pediatrics Business Group
Mark W. Leuchtenberger
President and Chief Executive Officer, Therion
Biologics Corporation
Ekkehart Hassels-Weiler
President, Eagle Advisors, Inc.
Hans-Werner Hector
Retired co-founder of SAP AG;
Founder of H.W. & J. Hector Foundation, Germany
Richard J. Meadows
Advisor,
CDP Capital - Technology Ventures
Francis P. Tally, M.D.
Executive Vice President, Scientific Affairs of
Cubist Pharmaceuticals, Inc.
Peter R. Wolfe, M.D.
Partner and Director of Research, Pacific Oaks Medical Group
|
|
